While age can influence NSCLC’s molecular landscape, for example, younger patients show higher rates of EGFR mutations (~40% in <40-year-olds vs. ~15% in >70-year-olds) [31,32], the miR-145-mediated ceRNA network and its hub genes (FN1, CCND1) appear robust across ages. The gene discussed is FN1; the disease is non-small cell lung carcinoma.